Reacta Healthcare develop and manufacture challenge meals for use in food allergy clinical trials. Building from this foundation we offer innovative development and manufacturing solutions across the food allergy space.
Reacta Healthcare, established in 2013, operates from a pharmaceutical manufacturing facility in Deeside, North Wales. It is licenced to manufacture challenge meals for use in clinical trials. These challenge meals are currently used to diagnose and monitor food allergy in numerous worldwide therapeutic trials. Patents for the challenge meals have been granted in a number of countries.
Reacta Healthcare is developing its in-house analytical capability and has plans in place for expansion into niche areas of food allergen development and manufacture. This will include all aspects from sourcing through to manufacture of end product.
We are looking to work with partners across this developing clinical space.
Our Capabilities
Certificate of GMP Compliance of a manufacturer certificate number : UK MIA(IMP) 53174 INSP IMP 53174/19385617-0003[I].
Secondary packaging operations restricted to open label, non-randomised activities associated with Non-IMPs / Auxiliary Medicinal Products for use as challenge agents in clinical trials.
Our Reacta Healthcare Teams
Reacta Healthcare News
Reacta Healthcare announces successful completion of £1m food allergy paediatric diagnostics project substantially funded by Innovate UK.
Reacta Healthcare, a clinical diagnostic company dedicated to providing innovative diagnostics for life-threatening food allergies,...
17
May
May
Reacta Healthcare strengthens Advisory Board in preparation for significant R&D and regulatory activities.
Reacta Healthcare Press Release – 30 January 2024 Reacta Healthcare is a diagnostics company...
29
Jan
Jan
Simon Thelwall-Jones appointed as CFO
Reacta Healthcare Press Release – 23 November 2023 Reacta Healthcare bolsters Board & Executive...
24
Nov
Nov
Reacta Healthcare appoints Kevin Hawkins as Head of Regulatory Affairs
Reacta Healthcare appoints Kevin Hawkins as Head of Regulatory Affairs 20 June 2023, Deeside, United...
27
Jun
Jun
New partnership with FAACT – Food Allergy & Anaphylaxis Connection Team
Reacta Healthcare is proud to partner with FAACT to support the needs of the food...
21
Jun
Jun
First major milestone reached for Reacta Healthcare £1m Innovate UK funded project
Reacta Healthcare is helping combat food allergies amongst paediatrics, addressing the unmet need for greater...
10
Feb
Feb
Senior hire to cement 2023 growth plans at Reacta Healthcare
Reacta Healthcare has appointed a new quality control manager to further expand and develop its...
20
Jan
Jan
My time at MEDICA 2022
By Dr Martin Wickham, Chief Commercial Officer, Reacta Healthcare Last month I had the...
09
Dec
Dec